Patents by Inventor Michiaki FUKUI

Michiaki FUKUI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Electrochromic device
    Patent number: 11884882
    Abstract: According to one embodiment, provided is an electrochromic device including an electrochromic layer, which contains a tungsten oxide material. The tungsten oxide material includes potassium-containing tungsten oxide particles having an average particle size of 100 nm or less. The potassium-containing tungsten oxide particles contain potassium within a range of 1 mol % to 50 mol %, and include a central section and a peripheral section adjacent to the central section. A periodicity of a crystal varies between the central section and the peripheral section.
    Type: Grant
    Filed: September 3, 2021
    Date of Patent: January 30, 2024
    Assignees: Toshiba Materials Co., Ltd., Hayashi Telempu Corporation
    Inventors: Daisuke Fukushi, Shuichi Saito, Michiaki Fukui
  • ELECTROCHROMIC DEVICE
    Publication number: 20220100045
    Abstract: According to one embodiment, provided is an electrochromic device including an electrochromic layer, which contains a tungsten oxide material. The tungsten oxide material includes potassium-containing tungsten oxide particles having an average particle size of 100 nm or less. The potassium-containing tungsten oxide particles contain potassium within a range of 1 mol % to 50 mol %, and include a central section and a peripheral section adjacent to the central section. A periodicity of a crystal varies between the central section and the peripheral section.
    Type: Application
    Filed: September 3, 2021
    Publication date: March 31, 2022
    Applicants: TOSHIBA MATERIALS CO., LTD., HAYASHI TELEMPU CORPORATION
    Inventors: Daisuke FUKUSHI, Shuichi SAITO, Michiaki FUKUI
  • INHIBITOR OF RENAL FIBROSIS IN DIABETIC NEPHROPATHY
    Publication number: 20210378997
    Abstract: The present invention provides a composition including citric acid, a pharmaceutically acceptable salt of citric acid, a hydrate of citric acid, a hydrate of the pharmaceutically acceptable salt of citric acid, or a mixture thereof. Administration or ingestion of the previous period composition inhibits renal fibrosis in diabetic nephropathy.
    Type: Application
    Filed: October 17, 2019
    Publication date: December 9, 2021
    Applicants: KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION, NIPPON CHEMIPHAR CO., LTD.
    Inventors: Michiaki FUKUI, Yoshitaka HASHIMOTO, Toshiki NAKAI, Shigeki UEYAMA, Noboru YAMAUCHI